N° of patients | 26 |
Age, mean years (range) | 66 (49-79) |
Gender, n° of patients (%) | |
Male | 21 (80.8%) |
Female | 5 (19.2%) |
Months of follow-up, median | 36 |
Histopathological stage, n° of patients (%) | |
TaG3 | 4 (15.4%) |
T1G3 | 14 (53.8%) |
Cis | 4 (15.4%) |
Ta/T1G3 + Cis | 4 (15.4%) |
Time from first diagnosis, months range | 3-9 |